Etienne BRAIN

Institut Curie

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Catherine Alix-Panabières

Associate Professor, Director

University Hospital of Montpellier

FRANCE

View details

Sophie Pilleron

University of Oxford

UNITED KINGDOM

View details

Judith Balmaña

Head

Hospital Universitari Vall d'Hebron

SPAIN

View details

Pierre-Louis Soubeyran

Professor of Medical Oncology

University of Bordeaux

FRANCE

View details

Patricia Ganz

Professor

University of California, Los Angeles

UNITED STATES

View details

Gabor Liposits

Aarhus University

DENMARK

View details

Jessica L. Krok-Schoen

The Ohio State University College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Etienne BRAIN

Research Interests

Explore related searches

Contact this professor

Articles (20)

Combination of olaparib, durvalumab and fulvestrant in patients with advanced ER+/HER2- breast cancer and selected genomic alterations: results of the DOLAF trial

Prognostic significance and predictive value of circulating tumor cells in invasive lobular breast carcinoma - an exploratory analysis of the STIC CTC trial

Updated cancer burden in oldest old: A population-based study using 2022 Globocan estimates

Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer

Adequate assessment yields appropriate care—the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group

Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers

Serious Health-Related Suffering Impairs Treatments and Survival in Older Patients With Cancer

Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort

Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis

Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials

Systemic Therapy in Older Patients With High-Risk Disease

Geriatric impairments were directly and indirectly associated with mortality in older patients with cancer: a structural equation analysis

Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study

Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer

Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts

Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT

New Frontiers for Fairer Breast Cancer Care in a Globalized World

Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial

VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study

Collaborators (7)

Catherine Alix-Panabières

Sophie Pilleron

Judith Balmaña

Pierre-Louis Soubeyran

Patricia Ganz

Gabor Liposits

Jessica L. Krok-Schoen

Make your next move.